drugset / Trial / NCT02078310
Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia
RandomizedParallel-groupQuadruple-blindBasic science
Summary
A Phase 1b/2, Randomized, Double-blind, Placebo-Controlled, Multiple Oral Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients with Dementia
Timeline
- Start
- 2014-02
- Primary completion
- 2014-08
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lumateperone | Small molecule | 20 mg | Oral |